Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder

Leuk Lymphoma. 2016;57(4):945-8. doi: 10.3109/10428194.2015.1083563. Epub 2015 Oct 8.

Heinz Läubli^{1

2}, Alexandar Tzankov³, Darius Juskevicius³, Lukas Degen⁴, Christoph Rochlitz¹, Frank Stenner-Liewen^{1

2}

¹ a Department of Internal Medicine , Division of Medical Oncology, University Hospital Basel , Switzerland .
² b Department of Biomedicine , Cancer Immunology Laboratory, University Hospital Basel , Switzerland .
³ c Institute of Pathology, University Hospital Basel , Switzerland , and.
⁴ d Division of Gastroenterology and Hepatology, University Hospital Basel , Switzerland.

No abstract available

Publication types